Ikbel Kooli
Ikbel Kooli has a total of 103 co-authors. Here are the top co-authors by number of shared publications:
Mohamed Chakroun
Department of Infectious Diseases, F. Bourguiba Teaching Hospital, University of Monastir, Monastir, Tunisia
10 shared publicationsAbir Aouam
Fattouma Bourguiba Hosp, Monastir, Tunisia
9 shared publicationsAdnene Toumi
Fattouma Bourguiba Hosp, Monastir, Tunisia
7 shared publicationsH. Ben Brahim
Service des maladies infectieuses, CHU de Fattouma-Bourguiba Monastir, Monastir, Tunisie
7 shared publicationsHajer Ben Brahim
Fattouma Bourguiba Hospital, Infectious Disease Department, 5000 Monastir, Tunisia
7 shared publicationsA. Aouam
Service des maladies infectieuses, CHU de Fattouma-Bourguiba Monastir, Monastir, Tunisie
6 shared publications
Latest Publications
- 7 September 2025
- Published by Termedia Sp. z.o.o. in HIV & AIDS Review
- Vol. 24 (3) , 195-200
Prevalence and associated factors of insulin resistance among HIV-infected patients receiving antiretroviral therapy: a cross-sectional study from Tunisia
Introduction: Antiretroviral therapy (ART) has significantly improved prognosis of human immunodeficiency virus (HIV) infection by reducing both morbidity and mortality rates. However, this therapy leads to an increased incidence of metabolic disorders, such as insulin resistance (IR). The aim...
- 7 September 2025
- Published by Termedia Sp. z.o.o. in HIV & AIDS Review
- Vol. 24 (3) , 195-200
Prevalence and associated factors of insulin resistance among HIV-infected patients receiving antiretroviral therapy: a cross-sectional study from Tunisia
Introduction: Antiretroviral therapy (ART) has significantly improved prognosis of human immunodeficiency virus (HIV) infection by reducing both morbidity and mortality rates. However, this therapy leads to an increased incidence of metabolic disorders, such as insulin resistance (IR). The aim...
- Open Access
- 18 February 2025
- Published by F1000 Research Ltd in F1000Research
- Vol. 14, 217
Case Report: First report of chronic osteomyelitis caused by Staphylococcus hyicus: a zoonotic pathogen with underreported clinical significance
Background Staphylococcus hyicus is a zoonotic pathogen primarily associated with animal infections. Human infections are exceedingly rare, with only six cases documented in the literature. The pathogen’s role in chronic osteomyelitis of long bones has not been previously reported, presenting unique diagnostic and therapeutic challenges. Case Report We report the first case of chronic osteomyelitis of long bones caused by methicillin-resistant S. hyicus in a 34-year-old male farmer with a history of recurrent osteomyelitis following trauma and livestock exposure. The patient presented with purulent discharge from two fistulae on the medial aspect of the right thigh. Imaging studies revealed bony sequestration, periosteal reaction, and multiple fistulous tracts consistent with Cierny-Mader stage III chronic osteomyelitis. Microbiological identification of coagulase-negative methicillin-resistant S. hyicus was achieved via culture and phenotypic analysis of aspirates from the fistulae and intraoperative samples, with confirmation via matrix-assisted laser desorption/ionization-time of flight mass spectrometry (MALDI-TOF MS). A multidisciplinary treatment strategy was implemented, combining extensive surgical debridement and dead space management with a 24-week tailored antibiotic regimen. The regimen included intravenous teicoplanin and ciprofloxacin for 14 days, followed by oral ciprofloxacin and cotrimoxazole. The patient achieved sustained remission with no recurrence at 2.5 years of follow-up. Conclusion This case underscores the zoonotic potential of S. hyicus and highlights its capacity to cause severe, persistent infections in humans, particularly in individuals with occupational or environmental exposure to livestock. Advanced diagnostic techniques such as MALDI-TOF MS are essential for accurate identification, mitigating the risk of misdiagnosis due to phenotypic similarities with other staphylococcal species. Clinicians should consider S. hyicus in the differential diagnosis of chronic osteomyelitis in patients with relevant exposure histories to enable timely and targeted therapeutic interventions.
- 18 February 2025
- Published by F1000 Research Ltd in F1000Research
- Vol. 14, 217
Open AccessCase Report: First report of chronic osteomyelitis caused by Staphylococcus hyicus: a zoonotic pathogen with underreported clinical significance
Background Staphylococcus hyicus is a zoonotic pathogen primarily associated with animal infections. Human infections are exceedingly rare, with only six cases documented in the literature. The pathogen’s role in chronic osteomyelitis of long bones has not been previously reported, presenting unique diagnostic and therapeutic challenges. Case Report We report the first case of chronic osteomyelitis of long bones caused by methicillin-resistant S. hyicus in a 34-year-old male farmer with a history of recurrent osteomyelitis following trauma and livestock exposure. The patient presented with purulent discharge from two fistulae on the medial aspect of the right thigh. Imaging studies revealed bony sequestration, periosteal reaction, and multiple fistulous tracts consistent with Cierny-Mader stage III chronic osteomyelitis. Microbiological identification of coagulase-negative methicillin-resistant S. hyicus was achieved via culture and phenotypic analysis of aspirates from the fistulae and intraoperative samples, with confirmation via matrix-assisted laser desorption/ionization-time of flight mass spectrometry (MALDI-TOF MS). A multidisciplinary treatment strategy was implemented, combining extensive surgical debridement and dead space management with a 24-week tailored antibiotic regimen. The regimen included intravenous teicoplanin and ciprofloxacin for 14 days, followed by oral ciprofloxacin and cotrimoxazole. The patient achieved sustained remission with no recurrence at 2.5 years of follow-up. Conclusion This case underscores the zoonotic potential of S. hyicus and highlights its capacity to cause severe, persistent infections in humans, particularly in individuals with occupational or environmental exposure to livestock. Advanced diagnostic techniques such as MALDI-TOF MS are essential for accurate identification, mitigating the risk of misdiagnosis due to phenotypic similarities with other staphylococcal species. Clinicians should consider S. hyicus in the differential diagnosis of chronic osteomyelitis in patients with relevant exposure histories to enable timely and targeted therapeutic interventions.
- Open Access
- 9 September 2024
- Published by F1000 Research Ltd in F1000Research
- Vol. 13, 1028
Case Report : Brucella infection of total knee arthroplasty - The first case report in an endemic country!
Prosthetic joint loosening due to Brucella spp. is a rare event. In this report, we describe a rare case of prosthetic infection caused by brucella. A 71-year-old woman reported a six-month history of progressing pain in the right prosthetic knee, which had been implanted for arthrosis four years prior to admission, associated with fever. No night sweats were noted. On examination, the right knee appeared slightly swollen and painful on mobilization, and the surgical wound was normal. Blood tests showed increased C-Reactive Protein (CRP) (34mg/L) and erythrocyte sedimentation rate (ESR) (34mm/hr). A CT scan of her right knee was performed, showing loosening of the prosthesis, joint effusion, and osteolysis in contact with the internal tibial component measuring 16mm maximum with bone remodeling of the epiphysis and metaphysis regions. Rose Bengal test was positive for brucellosis, a standard brucella tube agglutination test was positive at a titer of 1/80, blood cultures for brucella were negative and a PCR for detection of Mycobacterium tuberculosis was negative. The patient was diagnosed as having Brucella infection of his total knee arthroplasty. Favorable outcome was observed after medical and surgical treatment. We believe this is the first detailed report of Brucella prosthetic infection in the country despite the endemicity of this type of zoonosis.
- 9 September 2024
- Published by F1000 Research Ltd in F1000Research
- Vol. 13, 1028
Open AccessCase Report : Brucella infection of total knee arthroplasty - The first case report in an endemic country!
Prosthetic joint loosening due to Brucella spp. is a rare event. In this report, we describe a rare case of prosthetic infection caused by brucella. A 71-year-old woman reported a six-month history of progressing pain in the right prosthetic knee, which had been implanted for arthrosis four years prior to admission, associated with fever. No night sweats were noted. On examination, the right knee appeared slightly swollen and painful on mobilization, and the surgical wound was normal. Blood tests showed increased C-Reactive Protein (CRP) (34mg/L) and erythrocyte sedimentation rate (ESR) (34mm/hr). A CT scan of her right knee was performed, showing loosening of the prosthesis, joint effusion, and osteolysis in contact with the internal tibial component measuring 16mm maximum with bone remodeling of the epiphysis and metaphysis regions. Rose Bengal test was positive for brucellosis, a standard brucella tube agglutination test was positive at a titer of 1/80, blood cultures for brucella were negative and a PCR for detection of Mycobacterium tuberculosis was negative. The patient was diagnosed as having Brucella infection of his total knee arthroplasty. Favorable outcome was observed after medical and surgical treatment. We believe this is the first detailed report of Brucella prosthetic infection in the country despite the endemicity of this type of zoonosis.
- Open Access
- 1 January 2024
- Published by SAGE Publications in Sage Open Medical Case Reports
- Vol. 12
Diffuse Kaposi sarcoma with oral involvement in a person diagnosed with human immunodeficiency virus/acquired immune deficiency syndrome: A case report
Kaposi’s sarcoma is a well-known multifocal vascular tumor initially described by pathologist Moritz Kaposi. This report presents the case of a 38-year-old bisexual male who consulted the infectious diseases department with non-itchy maculopapular and purpuric lesions on the skin with the involvement of the oral mucosa, suggesting a diagnosis of Kaposi’s sarcoma. Biological and radiological investigations were performed. The patient was found to be human immunodeficiency virus positive with a viral load of 251.000/mL and a CD4 count of 182/mm3. In addition, secondary syphilis was diagnosed. Histopathological examinations confirmed HHV-8 KS. The patient was treated with Extencilline® and antiretroviral therapy. After 10 months of chemotherapy, a favorable outcome was noted with complete resolution of skin and oral mucosa lesions.
- 1 January 2024
- Published by SAGE Publications in Sage Open Medical Case Reports
- Vol. 12
Open AccessDiffuse Kaposi sarcoma with oral involvement in a person diagnosed with human immunodeficiency virus/acquired immune deficiency syndrome: A case report
Kaposi’s sarcoma is a well-known multifocal vascular tumor initially described by pathologist Moritz Kaposi. This report presents the case of a 38-year-old bisexual male who consulted the infectious diseases department with non-itchy maculopapular and purpuric lesions on the skin with the involvement of the oral mucosa, suggesting a diagnosis of Kaposi’s sarcoma. Biological and radiological investigations were performed. The patient was found to be human immunodeficiency virus positive with a viral load of 251.000/mL and a CD4 count of 182/mm3. In addition, secondary syphilis was diagnosed. Histopathological examinations confirmed HHV-8 KS. The patient was treated with Extencilline® and antiretroviral therapy. After 10 months of chemotherapy, a favorable outcome was noted with complete resolution of skin and oral mucosa lesions.
- 31 December 2022
- Published by OA Publishers Private Limited in Journal of Clinical and Medical Images, Case Reports
- Vol. 2 (6)
Atrioventricular block: Circumstance of discovering of covid 19
In Tunisia the first case was diagnosed on march 2020. Several were the clinical manifestations. Cardiovascular system is frequently affected. In this article we describe the case of a patient that atrioventricular block was the circumstance of discovering of Covid 19.
- 31 December 2022
- Published by OA Publishers Private Limited in Journal of Clinical and Medical Images, Case Reports
- Vol. 2 (6)
Atrioventricular block: Circumstance of discovering of covid 19
In Tunisia the first case was diagnosed on march 2020. Several were the clinical manifestations. Cardiovascular system is frequently affected. In this article we describe the case of a patient that atrioventricular block was the circumstance of discovering of Covid 19.
- 24 September 2022
- Published by Elsevier in Annales d'Endocrinologie
- Vol. 83 (5) , 362
Facteurs de risque des infections du pied diabétique à des bactéries multirésistantes
- 24 September 2022
- Published by Elsevier in Annales d'Endocrinologie
- Vol. 83 (5) , 362
Facteurs de risque des infections du pied diabétique à des bactéries multirésistantes
- Open Access
- 24 August 2022
- Published by AOSIS in Southern African Journal of HIV Medicine
- Vol. 23 (1) , 9
COVID-19 vaccine acceptance and associated factors among people living with HIV in the Middle East and North Africa region
Background: Identifying coronavirus disease 2019 (COVID-19) vaccine acceptance and associated factors among people living with HIV (PLHIV) in the Middle East and North Africa region is important to meet the need for broad-scale vaccination against COVID-19.Objectives: To investigate the COVID-19 vaccine acceptance rate and factors among PLHIV in the Middle East and North Africa region.Method: An online cross-sectional survey was conducted among PLHIV currently living in Egypt, Tunisia and Saudi Arabia between March 2021 and August 2021.Results: Of the 540 respondents, 19.3% reported already being vaccinated against COVID-19 (n = 104), 32.0% responded ‘definitely yes’ (n = 173), and 13.3% responded ‘probably yes’ (n = 72) for intention to receive a COVID-19 vaccine, with an overall COVID-19 vaccine acceptance rate of 64.6% among PLHIV in the region. The most significant predictors of COVID-19 vaccine acceptance included feeling less worried about COVID-19 transmission post-vaccination (221.0% higher odds), and believing the disease is vaccine-preventable (160.0% higher odds). Reported barriers to COVID-19 vaccine acceptance include concerns about vaccine effectiveness and belief that HIV medications protect against COVID-19 transmission, living in a rural area and reporting less-frequent engagement with HIV care. Nine out of 10 participants reported that the chances of them getting COVID-19 vaccine would increase if given adequate information and if their doctor recommended it.Conclusion: Findings of the study can help researchers, health officials, and other health system actors understand the predictors and barriers to COVID-19 vaccine acceptance reported by PLHIV. This understanding could inform the future planning of interventions tailored to PLHIV.
- 24 August 2022
- Published by AOSIS in Southern African Journal of HIV Medicine
- Vol. 23 (1) , 9
Open AccessCOVID-19 vaccine acceptance and associated factors among people living with HIV in the Middle East and North Africa region
Background: Identifying coronavirus disease 2019 (COVID-19) vaccine acceptance and associated factors among people living with HIV (PLHIV) in the Middle East and North Africa region is important to meet the need for broad-scale vaccination against COVID-19.Objectives: To investigate the COVID-19 vaccine acceptance rate and factors among PLHIV in the Middle East and North Africa region.Method: An online cross-sectional survey was conducted among PLHIV currently living in Egypt, Tunisia and Saudi Arabia between March 2021 and August 2021.Results: Of the 540 respondents, 19.3% reported already being vaccinated against COVID-19 (n = 104), 32.0% responded ‘definitely yes’ (n = 173), and 13.3% responded ‘probably yes’ (n = 72) for intention to receive a COVID-19 vaccine, with an overall COVID-19 vaccine acceptance rate of 64.6% among PLHIV in the region. The most significant predictors of COVID-19 vaccine acceptance included feeling less worried about COVID-19 transmission post-vaccination (221.0% higher odds), and believing the disease is vaccine-preventable (160.0% higher odds). Reported barriers to COVID-19 vaccine acceptance include concerns about vaccine effectiveness and belief that HIV medications protect against COVID-19 transmission, living in a rural area and reporting less-frequent engagement with HIV care. Nine out of 10 participants reported that the chances of them getting COVID-19 vaccine would increase if given adequate information and if their doctor recommended it.Conclusion: Findings of the study can help researchers, health officials, and other health system actors understand the predictors and barriers to COVID-19 vaccine acceptance reported by PLHIV. This understanding could inform the future planning of interventions tailored to PLHIV.
- 26 December 2021
- Published by Termedia Sp. z.o.o. in HIV & AIDS Review
- Vol. 20 (4) , 311-313
Unusual occurrence of hemophagocytic lymphohistiocytosis in HIV-positive person with visceral leishmaniasis
Introduction Visceral leishmaniasis is a well-recognized opportunistic infection in people living with HIV (PLHIV). Unlike adults, in children this infection is frequently associated with hemophagocytic lymphohistiocytosis (HLH). We report a case of HLH in HIV-positive person with...
- 26 December 2021
- Published by Termedia Sp. z.o.o. in HIV & AIDS Review
- Vol. 20 (4) , 311-313
Unusual occurrence of hemophagocytic lymphohistiocytosis in HIV-positive person with visceral leishmaniasis
Introduction Visceral leishmaniasis is a well-recognized opportunistic infection in people living with HIV (PLHIV). Unlike adults, in children this infection is frequently associated with hemophagocytic lymphohistiocytosis (HLH). We report a case of HLH in HIV-positive person with...
- 1 August 2021
- Published by Elsevier in Infectious Diseases Now
- Vol. 51 (5) , S89-S90
Tuberculose ostéoarticulaire : à propos de 35 cas
- 1 August 2021
- Published by Elsevier in Infectious Diseases Now
- Vol. 51 (5) , S89-S90
Tuberculose ostéoarticulaire : à propos de 35 cas
- Open Access
- 1 August 2021
- Published by Elsevier in Infectious Diseases Now
- Vol. 51 (5) , S68
Maladie à Coronavirus (COVID-19) : connaissance, attitude et pratiques du personnel de santé
- 1 August 2021
- Published by Elsevier in Infectious Diseases Now
- Vol. 51 (5) , S68
Open AccessMaladie à Coronavirus (COVID-19) : connaissance, attitude et pratiques du personnel de santé